Skip to main content
PMC home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1989 Mar;96(3):675–687. doi: 10.1111/j.1476-5381.1989.tb11868.x

Evidence for co-transmitter role of neuropeptide Y in the pig spleen.

J M Lundberg 1, A Rudehill 1, A Sollevi 1, B Hamberger 1
PMCID: PMC1854405  PMID: 2566349

Abstract

1. The possible involvement of neuropeptide Y (NPY) in relation to noradrenaline (NA) and adenosine triphosphate (ATP) mechanisms in the sympathetic nervous control of the vascular tone and capsule contraction in the blood perfused pig spleen was investigated in vivo. 2. Local injections or infusions of NA, NPY and alpha-, beta-methylene ATP (mATP) caused vasoconstriction (perfusion pressure increase) and capsule contraction (increased venous blood flow). ATP only evoked vasodilatation. NPY was about 50 fold more potent than NA as a vasoconstrictor, and the NPY response was more long-lasting. Reserpine treatment did not change the effects of NPY. 3. Electrical stimulation of the splenic nerves in control animals caused a frequency-dependent, guanethidine-sensitive output of both NPY-like immunoreactivity (-LI) and NA, suggesting co-release. The output of NPY-LI relative to NA was enhanced at high frequency stimulation. Furthermore, alpha-adrenoceptor blockade by phentolamine enhanced both the output of NPY-LI and NA while inhibition of the neuronal uptake of NA with desipramine reduced the low frequency stimulation-evoked overflow of NPY-LI. Preganglionic denervation did not change the output of NPY-LI or NA. 4. Reserpine treatment reduced both the splenic content of NA and NPY-LI. Preganglionic denervation inhibited the reserpine-induced depletion of the NPY content but not of NA in terminal areas. The stimulation-evoked NPY overflow was markedly enhanced, especially at low-frequency stimulation after reserpine, and the plasma levels of NPY-LI in the venous effluent were then in the nmolar range (i.e. where exogenous NPY induced vasoconstriction). The perfusion-pressure increase upon stimulation in reserpine-treated, preganglionically-denervated animals was highly correlated (r = 0.91) to the NPY overflow. The functional 0.5 Hz responses were reduced after reserpine, while at higher frequencies the functional effects were of similar magnitude to controls but longer-lasting. 5. Tyramine induced a release of NA but not of NPY-LI. Furthermore, the increase in perfusion pressure induced by tyramine was absent after reserpine. 6. After tachyphylaxis to the vasoconstrictor effects of mATP, the nerve stimulation-evoked, functional response as well as the NA and NPY-LI overflow were unchanged. After reserpine treatment, both the perfusion-pressure increase and NPY-LI overflow to nerve stimulation were reduced after mATP tachyphylaxis. 7. In conclusion, release of NPY rather than ATP may explain the long-lasting, non-adrenergic, splenic functional responses in reserpinized animals upon sympathetic stimulation. However, NA is most likely the main splenic transmitter when low-frequency stimulation is used under control conditions.(ABSTRACT TRUNCATED AT 400 WORDS)

Full text

PDF
675

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andén N. E., Henning M. Adrenergic nerve function, noradrenaline level and noradrenaline uptake in cat nictitating membrane after reserpine treatment. Acta Physiol Scand. 1966 Jul-Aug;67(3):498–504. doi: 10.1111/j.1748-1716.1966.tb03335.x. [DOI] [PubMed] [Google Scholar]
  2. Antonaccio M. J., Smith C. B. Effects of chronic pretreatment with small doses of reserpine upon adrenergic nerve function. J Pharmacol Exp Ther. 1974 Mar;188(3):654–667. [PubMed] [Google Scholar]
  3. Arnaiz J. M., García A. G., Horga J. F., Kirpekar S. M. Tissue and plasma catecholamines and dopamine beta-hydroxylase activity of various animal species after neurogenic sympathetic stimulation. J Physiol. 1978 Dec;285:515–529. doi: 10.1113/jphysiol.1978.sp012586. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. BOURA A. L., GREEN A. F. ADRENERGIC NEURONE BLOCKING AGENTS. Annu Rev Pharmacol. 1965;5:183–212. doi: 10.1146/annurev.pa.05.040165.001151. [DOI] [PubMed] [Google Scholar]
  5. BROWN G. L., DAVIES B. N., FERRY C. B. The effect of neuronal rest on the output of sympathetic transmitter from the spleen. J Physiol. 1961 Dec;159:365–380. doi: 10.1113/jphysiol.1961.sp006814. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Blaschke E., Uvnäs B. Effect of splenic nerve stimulation on the contents of noradrenaline, ATP and sulphomucopolysaccharides in noradrenergic vesicle fractions from the cat spleen. Acta Physiol Scand. 1979 Apr;105(4):496–507. doi: 10.1111/j.1748-1716.1979.tb00114.x. [DOI] [PubMed] [Google Scholar]
  7. Burnstock G., Kennedy C. A dual function for adenosine 5'-triphosphate in the regulation of vascular tone. Excitatory cotransmitter with noradrenaline from perivascular nerves and locally released inhibitory intravascular agent. Circ Res. 1986 Mar;58(3):319–330. doi: 10.1161/01.res.58.3.319. [DOI] [PubMed] [Google Scholar]
  8. Burnstock G., Warland J. J. A pharmacological study of the rabbit saphenous artery in vitro: a vessel with a large purinergic contractile response to sympathetic nerve stimulation. Br J Pharmacol. 1987 Jan;90(1):111–120. doi: 10.1111/j.1476-5381.1987.tb16830.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Cheng J. T., Shen C. L. Release of neuropeptide Y (NPY) induced by tyramine in the isolated vas deferens of rat. Naunyn Schmiedebergs Arch Pharmacol. 1987 Mar;335(3):255–260. doi: 10.1007/BF00172793. [DOI] [PubMed] [Google Scholar]
  10. Cubeddu L. X., Weiner N. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. V. Enhanced release associated with a granular effect of a benzoquinolizine derivative with reserpine-like properties. J Pharmacol Exp Ther. 1975 Jun;193(3):757–775. [PubMed] [Google Scholar]
  11. Cubeddu L., Barnes E. M., Langer S. Z., Weiner N. Release of norepinephrine and dopamine-beta-hydroxylase by nerve stimulation. I. Role of neuronal and extraneuronal uptake and of alpha presynaptic receptors. J Pharmacol Exp Ther. 1974 Sep;190(3):431–450. [PubMed] [Google Scholar]
  12. Delbro D., Hedlund H., Kennedy C., Burnstock G. Potent vasoconstrictor actions of alpha, beta-methylene ATP, a stable analogue of ATP, on the rat vasculature, in vivo. Acta Physiol Scand. 1985 Apr;123(4):501–503. doi: 10.1111/j.1748-1716.1985.tb07616.x. [DOI] [PubMed] [Google Scholar]
  13. Dixon W. R., Mosimann W. F., Weiner N. The role of presynatpic feedback mechanisms in regulation of norepinephrine release by nerve stimulation. J Pharmacol Exp Ther. 1979 May;209(2):196–204. [PubMed] [Google Scholar]
  14. Edvinsson L., Emson P., McCulloch J., Tatemoto K., Uddman R. Neuropeptide Y: cerebrovascular innervation and vasomotor effects in the cat. Neurosci Lett. 1983 Dec 23;43(1):79–84. doi: 10.1016/0304-3940(83)90132-5. [DOI] [PubMed] [Google Scholar]
  15. Fedan J. S., Hogaboom G. K., O'Donnell J. P., Colby J., Westfall D. P. Contribution by purines to the neurogenic response of the vas deferens of the guinea pig. Eur J Pharmacol. 1981 Jan 5;69(1):41–53. doi: 10.1016/0014-2999(81)90600-2. [DOI] [PubMed] [Google Scholar]
  16. Flavahan N. A., Grant T. L., Greig J., McGrath J. C. Analysis of the alpha-adrenoceptor-mediated, and other, components in the sympathetic vasopressor responses of the pithed rat. Br J Pharmacol. 1985 Sep;86(1):265–274. doi: 10.1111/j.1476-5381.1985.tb09458.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Frew R., Baer H. P. Adenosine-alpha, beta-methylene diphosphate effects in intestinal smooth muscle: sites of action and possible prostaglandin involvement. J Pharmacol Exp Ther. 1979 Dec;211(3):525–530. [PubMed] [Google Scholar]
  18. Fujioka M., Cheung D. W. Autoregulation of neuromuscular transmission in the guinea-pig saphenous artery. Eur J Pharmacol. 1987 Jul 9;139(2):147–153. doi: 10.1016/0014-2999(87)90246-9. [DOI] [PubMed] [Google Scholar]
  19. Hallman H., Farnebo L. O., Hamberger B., Johnsson G. A sensitive method for the determination of plasma catecholamines using liquid chromatography with electrochemical detection. Life Sci. 1978 Sep 11;23(10):1049–1052. doi: 10.1016/0024-3205(78)90665-3. [DOI] [PubMed] [Google Scholar]
  20. Katsuragi T., Su C. Purine release from vascular adrenergic nerves by high potassium and a calcium ionophore, A-23187. J Pharmacol Exp Ther. 1980 Dec;215(3):685–690. [PubMed] [Google Scholar]
  21. Kennedy C., Saville V. L., Burnstock G. The contributions of noradrenaline and ATP to the responses of the rabbit central ear artery to sympathetic nerve stimulation depend on the parameters of stimulation. Eur J Pharmacol. 1986 Apr 2;122(3):291–300. doi: 10.1016/0014-2999(86)90409-7. [DOI] [PubMed] [Google Scholar]
  22. Kirkpatrick K., Burnstock G. Sympathetic nerve-mediated release of ATP from the guinea-pig vas deferens is unaffected by reserpine. Eur J Pharmacol. 1987 Jun 19;138(2):207–214. doi: 10.1016/0014-2999(87)90434-1. [DOI] [PubMed] [Google Scholar]
  23. Lundberg J. M., Al-Saffar A., Saria A., Theodorsson-Norheim E. Reserpine-induced depletion of neuropeptide Y from cardiovascular nerves and adrenal gland due to enhanced release. Naunyn Schmiedebergs Arch Pharmacol. 1986 Feb;332(2):163–168. doi: 10.1007/BF00511407. [DOI] [PubMed] [Google Scholar]
  24. Lundberg J. M., Anggård A., Theodorsson-Norheim E., Pernow J. Guanethidine-sensitive release of neuropeptide Y-like immunoreactivity in the cat spleen by sympathetic nerve stimulation. Neurosci Lett. 1984 Nov 23;52(1-2):175–180. doi: 10.1016/0304-3940(84)90370-7. [DOI] [PubMed] [Google Scholar]
  25. Lundberg J. M., Fried G., Pernow J., Theodorsson-Norheim E., Anggård A. NPY--a mediator of reserpine-resistant, non-adrenergic vasoconstriction in cat spleen after preganglionic denervation? Acta Physiol Scand. 1986 Jan;126(1):151–152. doi: 10.1111/j.1748-1716.1986.tb07799.x. [DOI] [PubMed] [Google Scholar]
  26. Lundberg J. M., Hemsén A., Rudehill A., Härfstrand A., Larsson O., Sollevi A., Saria A., Hökfelt T., Fuxe K., Fredholm B. B. Neuropeptide Y- and alpha-adrenergic receptors in pig spleen: localization, binding characteristics, cyclic AMP effects and functional responses in control and denervated animals. Neuroscience. 1988 Feb;24(2):659–672. doi: 10.1016/0306-4522(88)90359-4. [DOI] [PubMed] [Google Scholar]
  27. Lundberg J. M., Hökfelt T. Multiple co-existence of peptides and classical transmitters in peripheral autonomic and sensory neurons--functional and pharmacological implications. Prog Brain Res. 1986;68:241–262. doi: 10.1016/s0079-6123(08)60242-3. [DOI] [PubMed] [Google Scholar]
  28. Lundberg J. M., Martinsson A., Hemsén A., Theodorsson-Norheim E., Svedenhag J., Ekblom B., Hjemdahl P. Co-release of neuropeptide Y and catecholamines during physical exercise in man. Biochem Biophys Res Commun. 1985 Nov 27;133(1):30–36. doi: 10.1016/0006-291x(85)91837-6. [DOI] [PubMed] [Google Scholar]
  29. Lundberg J. M., Rudehill A., Sollevi A., Theodorsson-Norheim E., Hamberger B. Frequency- and reserpine-dependent chemical coding of sympathetic transmission: differential release of noradrenaline and neuropeptide Y from pig spleen. Neurosci Lett. 1986 Jan 2;63(1):96–100. doi: 10.1016/0304-3940(86)90020-0. [DOI] [PubMed] [Google Scholar]
  30. Lundberg J. M., Saria A., Franco-Cereceda A., Hökfelt T., Terenius L., Goldstein M. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons. Naunyn Schmiedebergs Arch Pharmacol. 1985 Jan;328(3):331–340. doi: 10.1007/BF00515563. [DOI] [PubMed] [Google Scholar]
  31. Lundberg J. M., Stjarne L. Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens. Acta Physiol Scand. 1984 Mar;120(3):477–479. doi: 10.1111/j.1748-1716.1984.tb07410.x. [DOI] [PubMed] [Google Scholar]
  32. Lundberg J. M., Tatemoto K. Pancreatic polypeptide family (APP, BPP, NPY and PYY) in relation to sympathetic vasoconstriction resistant to alpha-adrenoceptor blockade. Acta Physiol Scand. 1982 Dec;116(4):393–402. doi: 10.1111/j.1748-1716.1982.tb07157.x. [DOI] [PubMed] [Google Scholar]
  33. Lundberg J. M., Terenius L., Hökfelt T., Martling C. R., Tatemoto K., Mutt V., Polak J., Bloom S., Goldstein M. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function. Acta Physiol Scand. 1982 Dec;116(4):477–480. doi: 10.1111/j.1748-1716.1982.tb07171.x. [DOI] [PubMed] [Google Scholar]
  34. Muramatsu I. The effect of reserpine on sympathetic, purinergic neurotransmission in the isolated mesenteric artery of the dog: a pharmacological study. Br J Pharmacol. 1987 Jul;91(3):467–474. doi: 10.1111/j.1476-5381.1987.tb11238.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Needleman P., Minkes M. S., Douglas J. R., Jr Stimulation of prostaglandin biosynthesis by adenine nucleotides. Profile of prostaglandin release by perfused organs. Circ Res. 1974 Apr;34(4):455–460. doi: 10.1161/01.res.34.4.455. [DOI] [PubMed] [Google Scholar]
  36. POTTER L. T., AXELROD J. PROPERTIES OF NOREPINEPHRINE STORAGE PARTICLES OF THE RAT HEART. J Pharmacol Exp Ther. 1963 Dec;142:299–305. [PubMed] [Google Scholar]
  37. Peart W. S. The nature of splenic sympathin. J Physiol. 1949 Jun 15;108(4):491–501. doi: 10.1113/jphysiol.1949.sp004352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Pernow J., Lundberg J. M., Kaijser L., Hjemdahl P., Theodorsson-Norheim E., Martinsson A., Pernow B. Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man. Clin Physiol. 1986 Dec;6(6):561–578. doi: 10.1111/j.1475-097x.1986.tb00789.x. [DOI] [PubMed] [Google Scholar]
  39. Pernow J., Saria A., Lundberg J. M. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control. Acta Physiol Scand. 1986 Feb;126(2):239–249. doi: 10.1111/j.1748-1716.1986.tb07811.x. [DOI] [PubMed] [Google Scholar]
  40. Rudehill A., Olcén M., Sollevi A., Hamberger B., Lundberg J. M. Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig. Acta Physiol Scand. 1987 Dec;131(4):517–523. doi: 10.1111/j.1748-1716.1987.tb08271.x. [DOI] [PubMed] [Google Scholar]
  41. Saria A., Theodorsson-Norheim E., Lundberg J. M. Evidence for specific neuropeptide Y-binding sites in rat brain synaptosomes. Eur J Pharmacol. 1984 Dec 15;107(1):105–107. doi: 10.1016/0014-2999(84)90098-0. [DOI] [PubMed] [Google Scholar]
  42. Sneddon P., Westfall D. P., Fedan J. S. Cotransmitters in the motor nerves of the guinea pig vas deferens: electrophysiological evidence. Science. 1982 Nov 12;218(4573):693–695. doi: 10.1126/science.6291151. [DOI] [PubMed] [Google Scholar]
  43. Stjärne L., Astrand P. Relative pre- and postjunctional roles of noradrenaline and adenosine 5'-triphosphate as neurotransmitters of the sympathetic nerves of guinea-pig and mouse vas deferens. Neuroscience. 1985 Mar;14(3):929–946. doi: 10.1016/0306-4522(85)90155-1. [DOI] [PubMed] [Google Scholar]
  44. Tatemoto K. Neuropeptide Y: complete amino acid sequence of the brain peptide. Proc Natl Acad Sci U S A. 1982 Sep;79(18):5485–5489. doi: 10.1073/pnas.79.18.5485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Theodorsson-Norheim E., Hemsén A., Lundberg J. M. Radioimmunoassay for neuropeptide Y (NPY): chromatographic characterization of immunoreactivity in plasma and tissue extracts. Scand J Clin Lab Invest. 1985 Jun;45(4):355–365. doi: 10.3109/00365518509161019. [DOI] [PubMed] [Google Scholar]
  46. Theodorsson-Norheim E. Kruskal-Wallis test: BASIC computer program to perform nonparametric one-way analysis of variance and multiple comparisons on ranks of several independent samples. Comput Methods Programs Biomed. 1986 Aug;23(1):57–62. doi: 10.1016/0169-2607(86)90081-7. [DOI] [PubMed] [Google Scholar]
  47. Wiklund N. P., Gustafsson L. E., Lundin J. Pre- and postjunctional modulation of cholinergic neuroeffector transmission by adenine nucleotides. Experiments with agonist and antagonist. Acta Physiol Scand. 1985 Dec;125(4):681–691. doi: 10.1111/j.1748-1716.1985.tb07771.x. [DOI] [PubMed] [Google Scholar]
  48. von Kügelgen I., Starke K. Noradrenaline and adenosine triphosphate as co-transmitters of neurogenic vasoconstriction in rabbit mesenteric artery. J Physiol. 1985 Oct;367:435–455. doi: 10.1113/jphysiol.1985.sp015834. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES